{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:30:40Z","timestamp":1792031440244,"version":"4.4.0"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["112-2314-B-038-122-MY3, 113-2314-B-038-066-MY3"],"award-info":[{"award-number":["112-2314-B-038-122-MY3, 113-2314-B-038-066-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["111-2314-B-038-093-MY3, 113-2314-B-038-009, 114-2314-B-038-159"],"award-info":[{"award-number":["111-2314-B-038-093-MY3, 113-2314-B-038-009, 114-2314-B-038-159"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["111-2314-B-038-093-MY3, 113-2314-B-038-009, 114-2314-B-038-159"],"award-info":[{"award-number":["111-2314-B-038-093-MY3, 113-2314-B-038-009, 114-2314-B-038-159"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","award":["DP2-TMU-114-O-01, 113TMU-WFH-09"],"award-info":[{"award-number":["DP2-TMU-114-O-01, 113TMU-WFH-09"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","award":["DP2-TMU-114-O-01, 113TMU-WFH-09"],"award-info":[{"award-number":["DP2-TMU-114-O-01, 113TMU-WFH-09"]}],"id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Aortic dissection (AD) is a life\u2011threatening vascular disorder with high mortality and no effective pharmacological treatment. Addressing its multicellular and dynamic pathology requires strategies that precisely modulate inflammatory and degenerative processes, yet existing targeted delivery approaches lack the spatiotemporal and cellular precision required. Here, we establish Galectin\u20113 (Gal\u20113) as a therapeutic delivery target for cardiovascular nanomedicine and introduce a modular, pathology\u2011tailored nanoplatform synergizing nitric oxide (NO) therapy with multi\u2011pathway intervention. Gal\u20113 is persistently expressed on inflamed endothelial cells, macrophages, and smooth muscle cells during AD progression, providing a tractable target for lesion\u2011specific engagement. The nanoparticles, created from a previously unexplored integration of a Gal\u20113\u2011binding polysaccharide, a nitric oxide\u2013generating peptide, and a hydrophobic drug carrier, uniquely combine triple responsiveness to pH, protease, and oxidative stress with on\u2011demand NO release and controlled resveratrol co\u2011delivery. In vitro, they enhanced uptake across pathological cell types and attenuated inflammatory and degenerative phenotypes. In vivo, they achieved early lesion targeting, &gt;\u200920\u2011fold aortic accumulation, and marked reductions in AD incidence, vascular degeneration, and mortality. This work establishes Gal\u20113\u2011targeted nanotherapy as a broadly applicable paradigm for pathology\u2011adaptive intervention in AD and one that may be adapted for broader cardiovascular applications.<\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>","DOI":"10.1186\/s12951-025-04012-7","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T16:55:38Z","timestamp":1768323338000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Pathology-tailored nanotherapy via Galectin-3-targeted and triple-responsive nanoparticles enables multimodal therapy against aortic dissection"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5068-500X","authenticated-orcid":false,"given":"Chi","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Lang","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Yi","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsai-Mu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Ming","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander T. H.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hsiung","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen Yuan","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Ying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Che","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fwu-Long","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"key":"4012_CR1","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1161\/CIRCULATIONAHA.117.031264","volume":"137","author":"A Evangelista","year":"2018","unstructured":"Evangelista A, Isselbacher EM, Bossone E, Gleason TG, Eusanio MD, Sechtem U, et al. Insights from the international registry of acute aortic dissection: a 20-year experience of collaborative clinical research. Circulation. 2018;137:1846\u201360. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.031264.","journal-title":"Circulation"},{"key":"4012_CR2","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1161\/01.CIR.0000087400.48663.19","volume":"108","author":"CA Nienaber","year":"2003","unstructured":"Nienaber CA, Eagle KA. Aortic dissection: new frontiers in diagnosis and management: part II: therapeutic management and follow-up. Circulation. 2003;108:772\u20138. https:\/\/doi.org\/10.1161\/01.CIR.0000087400.48663.19.","journal-title":"Circulation"},{"key":"4012_CR3","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1161\/CIRCULATIONAHA.109.886408","volume":"120","author":"CA Nienaber","year":"2009","unstructured":"Nienaber CA, Rousseau H, Eggebrecht H, Kische S, Fattori R, Rehders TC, et al. Randomized comparison of strategies for type B aortic dissection: the INvestigation of STEnt grafts in Aortic Dissection (INSTEAD) trial. Circulation. 2009;120:2519\u201328. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.886408.","journal-title":"Circulation"},{"key":"4012_CR4","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1161\/CIRCULATIONAHA.112.097097","volume":"126","author":"T Kurihara","year":"2012","unstructured":"Kurihara T, Shimizu-Hirota R, Shimoda M, Adachi T, Shimizu H, Weiss SJ, et al. Neutrophil-derived matrix metalloproteinase 9 triggers acute aortic dissection. Circulation. 2012;126:3070\u201380. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.112.097097.","journal-title":"Circulation"},{"key":"4012_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.106048","volume":"176","author":"Y Chen","year":"2022","unstructured":"Chen Y, He Y, Wei X, Jiang D-S. Targeting regulated cell death in aortic aneurysm and dissection therapy. Pharmacol Res. 2022;176:106048. https:\/\/doi.org\/10.1016\/j.phrs.2021.106048.","journal-title":"Pharmacol Res"},{"key":"4012_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121958","volume":"293","author":"C Ji","year":"2023","unstructured":"Ji C, Wang X, Xue B, Li S, Li J, Qiao B, et al. A fluorescent nano vector for early diagnosis and enhanced Interleukin-33 therapy of thoracic aortic dissection. Biomaterials. 2023;293:121958. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121958.","journal-title":"Biomaterials"},{"key":"4012_CR7","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jconrel.2024.12.015","volume":"378","author":"T-x Li","year":"2025","unstructured":"Li T-x, Yang Y-y, Zong J-b, Li M, Fu X-x, Jiang X-x, et al. Activated neutrophil membrane-coated tRF-Gly-CCC nanoparticles for the treatment of aortic dissection\/aneurysm. J Control Release. 2025;378:334\u201349. https:\/\/doi.org\/10.1016\/j.jconrel.2024.12.015.","journal-title":"J Control Release"},{"key":"4012_CR8","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1097\/PAS.0b013e318294adc3","volume":"37","author":"L Xu","year":"2013","unstructured":"Xu L, Burke A. Acute medial dissection of the ascending aorta: evolution of reactive histologic changes. Am J Surg Pathol. 2013;37:1275\u201382. https:\/\/doi.org\/10.1097\/PAS.0b013e318294adc3.","journal-title":"Am J Surg Pathol"},{"key":"4012_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.115.003023","volume":"9","author":"J Toczek","year":"2016","unstructured":"Toczek J, Meadows JL, Sadeghi MM. Novel molecular imaging approaches to abdominal aortic aneurysm risk stratification. Circ Cardiovasc Imaging. 2016;9:e003023. https:\/\/doi.org\/10.1161\/CIRCIMAGING.115.003023.","journal-title":"Circ Cardiovasc Imaging"},{"key":"4012_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202006484","volume":"17","author":"F Oroojalian","year":"2021","unstructured":"Oroojalian F, Beygi M, Baradaran B, Mokhtarzadeh A, Shahbazi MA. Immune cell membrane-coated biomimetic nanoparticles for targeted cancer therapy. Small. 2021;17:2006484. https:\/\/doi.org\/10.1002\/smll.202006484.","journal-title":"Small"},{"key":"4012_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202101349","volume":"11","author":"D Wang","year":"2022","unstructured":"Wang D, Wang S, Zhou Z, Bai D, Zhang Q, Ai X, et al. White blood cell membrane-coated nanoparticles: recent development and medical applications. Adv Healthc Mater. 2022;11:2101349. https:\/\/doi.org\/10.1002\/adhm.202101349.","journal-title":"Adv Healthc Mater"},{"key":"4012_CR12","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1161\/ATVBAHA.107.159160","volume":"28","author":"M Papaspyridonos","year":"2008","unstructured":"Papaspyridonos M, McNeill E, de Bono JP, Smith A, Burnand KG, Channon KM, et al. Galectin-3 is an amplifier of inflammation in atherosclerotic plaque progression through macrophage activation and monocyte chemoattraction. Arterioscler Thromb Vasc Biol. 2008;28:433\u201340. https:\/\/doi.org\/10.1161\/ATVBAHA.107.159160.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4012_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218257","volume":"21","author":"H-Y Lu","year":"2020","unstructured":"Lu H-Y, Shih C-M, Huang C-Y, Wu AT, Cheng T-M, Mi F-L, et al. Galectin-3 modulates macrophage activation and contributes smooth muscle cells apoptosis in abdominal aortic aneurysm pathogenesis. Int J Mol Sci. 2020;21:8257. https:\/\/doi.org\/10.3390\/ijms21218257.","journal-title":"Int J Mol Sci"},{"key":"4012_CR14","doi-asserted-by":"publisher","DOI":"10.14336\/AD.2018.1001","volume":"10","author":"T Li","year":"2019","unstructured":"Li T, Zha L, Luo H, Li S, Zhao L, He J, et al. Galectin-3 mediates endothelial-to-mesenchymal transition in pulmonary arterial hypertension. Aging Dis. 2019;10:731. https:\/\/doi.org\/10.14336\/AD.2018.1001.","journal-title":"Aging Dis"},{"key":"4012_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21239232","volume":"21","author":"V Blanda","year":"2020","unstructured":"Blanda V, Bracale UM, Di Taranto MD, Fortunato G. Galectin-3 in cardiovascular diseases. Int J Mol Sci. 2020;21:9232. https:\/\/doi.org\/10.3390\/ijms21239232.","journal-title":"Int J Mol Sci"},{"key":"4012_CR16","doi-asserted-by":"publisher","first-page":"10990","DOI":"10.1002\/jcp.27910","volume":"234","author":"X Chen","year":"2019","unstructured":"Chen X, Lin J, Hu T, Ren Z, Li L, Hameed I, et al. Galectin-3 exacerbates ox\u2010LDL\u2010mediated endothelial injury by inducing inflammation via integrin \u03b21\u2010RhoA\u2010JNK signaling activation. J Cell Physiol. 2019;234:10990\u20131000. https:\/\/doi.org\/10.1002\/jcp.27910.","journal-title":"J Cell Physiol"},{"key":"4012_CR17","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.1172\/JCI38308","volume":"119","author":"BC Tieu","year":"2009","unstructured":"Tieu BC, Lee C, Sun H, LeJeune W, Recinos A, Ju X, et al. An adventitial IL-6\/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. J Clin Invest. 2009;119:3637\u201351. https:\/\/doi.org\/10.1172\/JCI38308.","journal-title":"J Clin Invest"},{"key":"4012_CR18","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/cvr\/cvt206","volume":"100","author":"S Menini","year":"2013","unstructured":"Menini S, Iacobini C, Ricci C, Blasetti Fantauzzi C, Salvi L, Pesce CM, et al. The galectin-3\/RAGE dyad modulates vascular osteogenesis in atherosclerosis. Cardiovasc Res. 2013;100:472\u201380. https:\/\/doi.org\/10.1093\/cvr\/cvt206.","journal-title":"Cardiovasc Res"},{"key":"4012_CR19","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00395-024-01053-1","volume":"119","author":"BH Ganizada","year":"2024","unstructured":"Ganizada BH, Veltrop RJ, Akbulut AC, Koenen RR, Accord R, Lorusso R, et al. Unveiling cellular and molecular aspects of ascending thoracic aortic aneurysms and dissections. Basic Res Cardiol. 2024;119:371\u201395. https:\/\/doi.org\/10.1007\/s00395-024-01053-1.","journal-title":"Basic Res Cardiol"},{"key":"4012_CR20","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1161\/ATVBAHA.112.300569","volume":"33","author":"L Calvier","year":"2013","unstructured":"Calvier L, Miana M, Reboul P, Cachofeiro V, Martinez-Martinez E, De Boer RA, et al. Galectin-3 mediates aldosterone-induced vascular fibrosis. Arterioscler Thromb Vasc Biol. 2013;33:67\u201375. https:\/\/doi.org\/10.1161\/ATVBAHA.112.300569.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4012_CR21","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1161\/HYPERTENSIONAHA.115.06032","volume":"66","author":"E Mart\u00ednez-Mart\u00ednez","year":"2015","unstructured":"Mart\u00ednez-Mart\u00ednez E, L\u00f3pez-\u00c1ndres N, Jurado-L\u00f3pez R, Rousseau E, Bartolom\u00e9 MV, Fern\u00e1ndez-Celis A, et al. Galectin-3 participates in cardiovascular remodeling associated with obesity. Hypertension. 2015;66:961\u20139. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.06032.","journal-title":"Hypertension"},{"key":"4012_CR22","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1161\/HYPERTENSIONAHA.115.06161","volume":"67","author":"G Vergaro","year":"2016","unstructured":"Vergaro G, Prud\u2019Homme M, Fazal L, Merval R, Passino C, Emdin M, et al. Inhibition of galectin-3 pathway prevents isoproterenol-induced left ventricular dysfunction and fibrosis in mice. Hypertension. 2016;67:606\u201312. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.115.06161.","journal-title":"Hypertension"},{"key":"4012_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-016-0236-3","volume":"14","author":"S Dobiasch","year":"2016","unstructured":"Dobiasch S, Szanyi S, Kjaev A, Werner J, Strauss A, Weis C, et al. Synthesis and functionalization of protease-activated nanoparticles with tissue plasminogen activator peptides as targeting moiety and diagnostic tool for pancreatic cancer. J Nanobiotechnology. 2016;14:1\u201318. https:\/\/doi.org\/10.1186\/s12951-016-0236-3.","journal-title":"J Nanobiotechnology"},{"key":"4012_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201900661","volume":"8","author":"X Ma","year":"2019","unstructured":"Ma X, Li X, Shi J, Yao M, Zhang X, Hou R, et al. Host\u2013guest polypyrrole nanocomplex for three-stimuli\u2010responsive drug delivery and imaging\u2010guided chemo\u2010photothermal synergetic therapy of refractory thyroid cancer. Adv Healthc Mater. 2019;8:1900661. https:\/\/doi.org\/10.1002\/adhm.201900661.","journal-title":"Adv Healthc Mater"},{"key":"4012_CR25","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1021\/acs.biomac.0c00358","volume":"21","author":"B Balakrishnan","year":"2020","unstructured":"Balakrishnan B, Subramanian S, Mallia MB, Repaka K, Kaur S, Chandan R, et al. Multifunctional core\u2013shell glyconanoparticles for galectin-3-targeted, trigger-responsive combination chemotherapy. Biomacromolecules. 2020;21:2645\u201360. https:\/\/doi.org\/10.1021\/acs.biomac.0c00358.","journal-title":"Biomacromolecules"},{"key":"4012_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12951-021-01115-9","volume":"19","author":"S Bai","year":"2021","unstructured":"Bai S, Sun Y, Cheng Y, Ye W, Jiang C, Liu M, et al. MCP mediated active targeting calcium phosphate hybrid nanoparticles for the treatment of orthotopic drug-resistant colon cancer. J Nanobiotechnology. 2021;19:1\u201320. https:\/\/doi.org\/10.1186\/s12951-021-01115-9.","journal-title":"J Nanobiotechnology"},{"key":"4012_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.202100643","volume":"31","author":"N Buaron","year":"2021","unstructured":"Buaron N, Mangraviti A, Volpin F, Liu A, Pedone M, Sankey E, et al. Pectic galactan polysaccharide-based gene delivery system for targeting neuroinflammation. Adv Funct Mater. 2021;31:2100643. https:\/\/doi.org\/10.1002\/adfm.202100643.","journal-title":"Adv Funct Mater"},{"key":"4012_CR28","doi-asserted-by":"publisher","first-page":"3325","DOI":"10.1039\/D4TB01682C","volume":"13","author":"KD Perera","year":"2025","unstructured":"Perera KD, Ghumman M, Sorkhdini P, Norbrun C, Negash S, Zhou Y, et al. Citrus pectin-coated inhalable PLGA nanoparticles for treatment of pulmonary fibrosis. J Mater Chem B. 2025;13:3325\u201339. https:\/\/doi.org\/10.1039\/D4TB01682C.","journal-title":"J Mater Chem B"},{"key":"4012_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2020.116526","volume":"245","author":"D Wu","year":"2020","unstructured":"Wu D, Zheng J, Hu W, Zheng X, He Q, Linhardt RJ, et al. Structure-activity relationship of citrus segment membrane RG-I pectin against Galectin-3: the galactan is not the only important factor. Carbohydr Polym. 2020;245:116526. https:\/\/doi.org\/10.1016\/j.carbpol.2020.116526.","journal-title":"Carbohydr Polym"},{"key":"4012_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.102330","volume":"35","author":"C Lin","year":"2025","unstructured":"Lin C, Mi F-L, Cha C-Y, Hsu F-Y, Ayu Ulfadillah S, Tsai M-L, et al. Structurally reprogrammed modified citrus pectin (MCP) enables potentiated galectin-3 sequestration and injectable carboxymethyl chitosan\/berberine hydrogel construction for osteoarthritis immunotherapy. Mater Today Bio. 2025;102330. https:\/\/doi.org\/10.1016\/j.mtbio.2025.102330.","journal-title":"Mater Today Bio"},{"key":"4012_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/nu11112619","volume":"11","author":"I Eliaz","year":"2019","unstructured":"Eliaz I, Raz A. Pleiotropic effects of modified citrus pectin. Nutrients. 2019;11:2619. https:\/\/doi.org\/10.3390\/nu11112619.","journal-title":"Nutrients"},{"key":"4012_CR32","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.bioactmat.2024.03.010","volume":"37","author":"J Li","year":"2024","unstructured":"Li J, Zhang J, Yu P, Xu H, Wang M, Chen Z, et al. ROS-responsive & scavenging NO nanomedicine for vascular diseases treatment by inhibiting endoplasmic reticulum stress and improving NO bioavailability. Bioact Mater. 2024;37:239\u201352. https:\/\/doi.org\/10.1016\/j.bioactmat.2024.03.010.","journal-title":"Bioact Mater"},{"key":"4012_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2024.152755","volume":"493","author":"C Lin","year":"2024","unstructured":"Lin C, Cheng T-M, Liu Y-C, Hsu F-Y, Shih C-M, Tsai M-L, et al. Dual-targeting EGCG\/NO-supplying protein assembled nanoparticles with multi-synergistic effects against atherosclerosis. Chem Eng J. 2024;493:152755. https:\/\/doi.org\/10.1016\/j.cej.2024.152755.","journal-title":"Chem Eng J"},{"key":"4012_CR34","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.biomaterials.2015.06.016","volume":"63","author":"Z Yang","year":"2015","unstructured":"Yang Z, Yang Y, Xiong K, Li X, Qi P, Tu Q, et al. Nitric oxide producing coating mimicking endothelium function for multifunctional vascular stents. Biomaterials. 2015;63:80\u201392. https:\/\/doi.org\/10.1016\/j.biomaterials.2015.06.016.","journal-title":"Biomaterials"},{"key":"4012_CR35","doi-asserted-by":"publisher","first-page":"4972","DOI":"10.1021\/acs.biomac.0c01176","volume":"21","author":"Y Oh","year":"2020","unstructured":"Oh Y, Jeong H, Lim S, Hong J. Controlled nitric oxide release using poly (lactic-co-glycolic acid) nanoparticles for anti-inflammatory effects. Biomacromolecules. 2020;21:4972\u20139. https:\/\/doi.org\/10.1021\/acs.biomac.0c01176.","journal-title":"Biomacromolecules"},{"key":"4012_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/antiox10040516","volume":"10","author":"J Bonetti","year":"2021","unstructured":"Bonetti J, Corti A, Lerouge L, Pompella A, Gaucher C. Phenotypic modulation of macrophages and vascular smooth muscle cells in atherosclerosis\u2014nitro-redox interconnections. Antioxidants. 2021;10:516. https:\/\/doi.org\/10.3390\/antiox10040516.","journal-title":"Antioxidants"},{"key":"4012_CR37","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2019.01.42","volume":"11","author":"G-G Ma","year":"2019","unstructured":"Ma G-G, Hao G-W, Lai H, Yang X-M, Liu L, Wang C-S, et al. Initial clinical impact of inhaled nitric oxide therapy for refractory hypoxemia following type A acute aortic dissection surgery. J Thorac Dis. 2019;11:495. https:\/\/doi.org\/10.21037\/jtd.2019.01.42.","journal-title":"J Thorac Dis"},{"key":"4012_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13019-020-1069-6","volume":"15","author":"H Zhang","year":"2020","unstructured":"Zhang H, Liu Y, Meng X, Yang D, Shi S, Liu J, et al. Effects of inhaled nitric oxide for postoperative hypoxemia in acute type A aortic dissection: a retrospective observational study. J Cardiothorac Surg. 2020;15:1\u20139. https:\/\/doi.org\/10.1186\/s13019-020-1069-6.","journal-title":"J Cardiothorac Surg"},{"key":"4012_CR39","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/FJC.0000000000000837","volume":"76","author":"K Wang","year":"2020","unstructured":"Wang K, Zhao J, Zhang W, Zhu M, Xu M, Li D, et al. Resveratrol attenuates aortic dissection by increasing endothelial barrier function through the SIRT1 pathway. J Cardiovasc Pharmacol. 2020;76:86\u201393. https:\/\/doi.org\/10.1097\/FJC.0000000000000837.","journal-title":"J Cardiovasc Pharmacol"},{"key":"4012_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122249","volume":"335","author":"Y Tao","year":"2023","unstructured":"Tao Y, Li G, Yang Y, Wang Z, Wang S, Li X, et al. Epigenomics in aortic dissection: from mechanism to therapeutics. Life Sci. 2023;335:122249. https:\/\/doi.org\/10.1016\/j.lfs.2023.122249.","journal-title":"Life Sci"},{"key":"4012_CR41","doi-asserted-by":"publisher","unstructured":"Bosshardt D, Van Andel M, Schrauben E, Gottwald L, Van Kimmenade R, Scholte A et al. The effect of resveratrol on aortic growth and function in patients with marfan syndrome. European Heart Journal. 2023;44:ehad655. 2033. https:\/\/doi.org\/10.1136\/heartjnl-2024-324343","DOI":"10.1136\/heartjnl-2024-324343"},{"key":"4012_CR42","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1161\/ATVBAHA.116.307841","volume":"36","author":"S Hibender","year":"2016","unstructured":"Hibender S, Franken R, Van Roomen C, Ter Braake A, Van Der Made I, Schermer EE, et al. Resveratrol inhibits aortic root dilatation in the Fbn1C1039G\/+ Marfan mouse model. Arterioscler Thromb Vasc Biol. 2016;36:1618\u201326. https:\/\/doi.org\/10.1161\/ATVBAHA.116.307841.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"4012_CR43","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2021.05.001","volume":"515","author":"B Ren","year":"2021","unstructured":"Ren B, Kwah MX-Y, Liu C, Ma Z, Shanmugam MK, Ding L, et al. Resveratrol for cancer therapy: challenges and future perspectives. Cancer Lett. 2021;515:63\u201372. https:\/\/doi.org\/10.1016\/j.canlet.2021.05.001.","journal-title":"Cancer Lett"},{"key":"4012_CR44","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jconrel.2011.09.083","volume":"158","author":"A Amri","year":"2012","unstructured":"Amri A, Chaumeil J, Sfar S, Charrueau C. Administration of resveratrol: what formulation solutions to bioavailability limitations? J Control Release. 2012;158:182\u201393. https:\/\/doi.org\/10.1016\/j.jconrel.2011.09.083.","journal-title":"J Control Release"},{"key":"4012_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41698-017-0038-6","volume":"1","author":"AY Berman","year":"2017","unstructured":"Berman AY, Motechin RA, Wiesenfeld MY, Holz MK. The therapeutic potential of resveratrol: a review of clinical trials. NPJ Precis Oncol. 2017;1:35. https:\/\/doi.org\/10.1038\/s41698-017-0038-6.","journal-title":"NPJ Precis Oncol"},{"key":"4012_CR46","doi-asserted-by":"publisher","DOI":"10.1053\/j.semtcvs.2020.02.023","author":"CS Ong","year":"2020","unstructured":"Ong CS, Nam L, Yesantharao P, Dong J, Canner JK, Teuben RJ, et al. The strongest risk factor for operative mortality in acute type A aortic dissection is acidosis: validation of risk model. Semin Thorac Cardiovasc Surg. 2020. https:\/\/doi.org\/10.1053\/j.semtcvs.2020.02.023.","journal-title":"Semin Thorac Cardiovasc Surg."},{"key":"4012_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/antiox12051106","volume":"12","author":"J Pincemail","year":"2023","unstructured":"Pincemail J, Tchana-Sato V, Courtois A, Musumeci L, Cheramy-Bien J-P, Munten J, et al. Alteration of blood oxidative stress status in patients with thoracic aortic dissection: a pilot study. Antioxidants. 2023;12:1106. https:\/\/doi.org\/10.3390\/antiox12051106.","journal-title":"Antioxidants"},{"key":"4012_CR48","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.ijbiomac.2020.07.124","volume":"164","author":"X Wang","year":"2020","unstructured":"Wang X, Parvathaneni V, Shukla SK, Kulkarni NS, Muth A, Kunda NK, et al. Inhalable resveratrol-cyclodextrin complex loaded biodegradable nanoparticles for enhanced efficacy against non-small cell lung cancer. Int J Biol Macromol. 2020;164:638\u201350. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.07.124.","journal-title":"Int J Biol Macromol"},{"key":"4012_CR49","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.addr.2011.09.006","volume":"64","author":"AE Felber","year":"2012","unstructured":"Felber AE, Dufresne M-H, Leroux J-C. pH-sensitive vesicles, polymeric micelles, and nanospheres prepared with polycarboxylates. Adv Drug Deliv Rev. 2012;64:979\u201392. https:\/\/doi.org\/10.1016\/j.addr.2011.09.006.","journal-title":"Adv Drug Deliv Rev"},{"key":"4012_CR50","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.carbpol.2013.11.037","volume":"102","author":"A Fernandes","year":"2014","unstructured":"Fernandes A, Ivanova G, Br\u00e1s NF, Mateus N, Ramos MJ, Rangel M, et al. Structural characterization of inclusion complexes between cyanidin-3-O-glucoside and \u03b2-cyclodextrin. Carbohydr Polym. 2014;102:269\u201377.","journal-title":"Carbohydr Polym"},{"key":"4012_CR51","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1039\/D4RA06269H","volume":"15","author":"M Hadadian","year":"2025","unstructured":"Hadadian M, Allahyari R, Mahdavi B, Rezaei-Seresht E. Design, characterization, and in vitro evaluation of magnetic carboxymethylated \u03b2-cyclodextrin as a pH-sensitive carrier system for amantadine delivery: a novel approach for targeted drug delivery. RSC Adv. 2025;15:446\u201359. https:\/\/doi.org\/10.1039\/D4RA06269H.","journal-title":"RSC Adv"},{"key":"4012_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ultsonch.2020.105322","volume":"70","author":"W Wang","year":"2021","unstructured":"Wang W, Feng Y, Chen W, Adie K, Liu D, Yin Y. Citrus pectin modified by microfluidization and ultrasonication: improved emulsifying and encapsulation properties. Ultrason Sonochem. 2021;70:105322. https:\/\/doi.org\/10.1016\/j.ultsonch.2020.105322.","journal-title":"Ultrason Sonochem"},{"key":"4012_CR53","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ijpharm.2019.03.063","volume":"564","author":"Z Hammoud","year":"2019","unstructured":"Hammoud Z, Khreich N, Auezova L, Fourmentin S, Elaissari A, Greige-Gerges H. Cyclodextrin-membrane interaction in drug delivery and membrane structure maintenance. Int J Pharm. 2019;564:59\u201376. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.03.063.","journal-title":"Int J Pharm"},{"key":"4012_CR54","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.addr.2013.05.001","volume":"65","author":"J Zhang","year":"2013","unstructured":"Zhang J, Ma PX. Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspective. Adv Drug Deliv Rev. 2013;65:1215\u201333. https:\/\/doi.org\/10.1016\/j.addr.2013.05.001.","journal-title":"Adv Drug Deliv Rev"},{"key":"4012_CR55","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1161\/HYPERTENSIONAHA.119.14485","volume":"76","author":"C-L Liu","year":"2020","unstructured":"Liu C-L, Liu X, Wang Y, Deng Z, Liu T, Sukhova GK, et al. Reduced Nhe1 (Na+-H\u2009+\u2009Exchanger-1) function protects ApoE-deficient mice from Ang II (Angiotensin II)\u2013induced abdominal aortic aneurysms. Hypertension. 2020;76:87\u2013100. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.119.14485.","journal-title":"Hypertension"},{"key":"4012_CR56","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.jtcvs.2007.11.017","volume":"136","author":"M Liao","year":"2008","unstructured":"Liao M, Liu Z, Bao J, Zhao Z, Hu J, Feng X, et al. A proteomic study of the aortic media in human thoracic aortic dissection: implication for oxidative stress. J Thorac Cardiovasc Surg. 2008;136:65\u201372. https:\/\/doi.org\/10.1016\/j.jtcvs.2007.11.017.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"4012_CR57","doi-asserted-by":"publisher","first-page":"E363","DOI":"10.1073\/pnas.1704637115","volume":"115","author":"AM Porras","year":"2018","unstructured":"Porras AM, Westlund JA, Evans AD, Masters KS. Creation of disease-inspired biomaterial environments to mimic pathological events in early calcific aortic valve disease. Proc Natl Acad Sci U S A. 2018;115:E363-71. https:\/\/doi.org\/10.1073\/pnas.1704637115.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4012_CR58","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1021\/nn901146y","volume":"4","author":"R Kumar","year":"2010","unstructured":"Kumar R, Roy I, Ohulchanskky TY, Vathy LA, Bergey EJ, Sajjad M, et al. In Vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano. 2010;4:699\u2013708. https:\/\/doi.org\/10.1021\/nn901146y.","journal-title":"ACS Nano"},{"key":"4012_CR59","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7252943","volume":"2019","author":"C Pei","year":"2019","unstructured":"Pei C, Wang X, Lin Y, Fang L, Meng S. Inhibition of galectin-3 alleviates cigarette smoke extract\u2010induced autophagy and dysfunction in endothelial progenitor cells. Oxid Med Cell Longev. 2019;2019:7252943. https:\/\/doi.org\/10.1155\/2019\/7252943.","journal-title":"Oxid Med Cell Longev"},{"key":"4012_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105725","volume":"170","author":"N Parsamanesh","year":"2021","unstructured":"Parsamanesh N, Asghari A, Sardari S, Tasbandi A, Jamialahmadi T, Xu S, et al. Resveratrol and endothelial function: a literature review. Pharmacol Res. 2021;170:105725. https:\/\/doi.org\/10.1016\/j.phrs.2021.105725.","journal-title":"Pharmacol Res"},{"key":"4012_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00054","volume":"11","author":"X Wang","year":"2020","unstructured":"Wang X, Zhang H, Cao L, He Y, Ma A, Guo W. The role of macrophages in aortic dissection. Front Physiol. 2020;11:54. https:\/\/doi.org\/10.3389\/fphys.2020.00054.","journal-title":"Front Physiol"},{"key":"4012_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2021.118864","volume":"277","author":"X Pan","year":"2022","unstructured":"Pan X, Wang H, Zheng Z, Huang X, Yang L, Liu J, et al. Pectic polysaccharide from Smilax china L. ameliorated ulcerative colitis by inhibiting the galectin-3\/NLRP3 inflammasome pathway. Carbohydr Polym. 2022;277:118864. https:\/\/doi.org\/10.1016\/j.carbpol.2021.118864.","journal-title":"Carbohydr Polym"},{"key":"4012_CR63","doi-asserted-by":"publisher","unstructured":"Wang Z, Zhang S, Xiao Y, Zhang W, Wu S, Qin T et al. NLRP3 inflammasome and inflammatory diseases. Oxidative medicine and cellular longevity. 2020;2020:4063562. https:\/\/doi.org\/10.3389\/fphys.2020.00054","DOI":"10.3389\/fphys.2020.00054"},{"key":"4012_CR64","first-page":"401","volume-title":"A new editor of smooth muscle phenotype","author":"R Liu","year":"2016","unstructured":"Liu R, Bauer AJ, Martin KA. A new editor of smooth muscle phenotype. Volume 119. Hagerstown, MD: Lippincott Williams & Wilkins; 2016. pp. 401\u20133."},{"key":"4012_CR65","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/cvr\/cvy022","volume":"114","author":"S Allahverdian","year":"2018","unstructured":"Allahverdian S, Chaabane C, Boukais K, Francis GA, Bochaton-Piallat M-L. Smooth muscle cell fate and plasticity in atherosclerosis. Cardiovasc Res. 2018;114:540\u201350. https:\/\/doi.org\/10.1093\/cvr\/cvy022.","journal-title":"Cardiovasc Res"},{"key":"4012_CR66","doi-asserted-by":"publisher","first-page":"9579","DOI":"10.3892\/mmr.2017.7810","volume":"16","author":"S Mu","year":"2017","unstructured":"Mu S, Guo S, Wang X, Zhan Y, Li Y, Jiang Y, et al. Effects of deferoxamine on the osteogenic differentiation of human periodontal ligament cells. Mol Med Rep. 2017;16:9579\u201386. https:\/\/doi.org\/10.3892\/mmr.2017.7810.","journal-title":"Mol Med Rep"},{"key":"4012_CR67","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1161\/CIRCRESAHA.120.318479","volume":"129","author":"F Hartmann","year":"2021","unstructured":"Hartmann F, Gorski DJ, Newman AA, Homann S, Petz A, Owsiany KM, et al. SMC-Derived Hyaluronan Modulates Vascular SMC Phenotype in Murine Atherosclerosis. Circ Res. 2021;129:992\u20131005. https:\/\/doi.org\/10.1161\/CIRCRESAHA.120.318479.","journal-title":"Circ Res"},{"key":"4012_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-022-00993-2","volume":"20","author":"G Cao","year":"2022","unstructured":"Cao G, Xuan X, Hu J, Zhang R, Jin H, Dong H. How vascular smooth muscle cell phenotype switching contributes to vascular disease. Cell Commun Signal. 2022;20:180. https:\/\/doi.org\/10.1186\/s12964-022-00993-2.","journal-title":"Cell Commun Signal"},{"key":"4012_CR69","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2115217119","volume":"119","author":"H Wu","year":"2022","unstructured":"Wu H, Shen Y, Sivagurunathan S, Weber MS, Adam SA, Shin JH, et al. Vimentin intermediate filaments and filamentous actin form unexpected interpenetrating networks that redefine the cell cortex. Proc Natl Acad Sci U S A. 2022;119:e2115217119. https:\/\/doi.org\/10.1073\/pnas.2115217119.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4012_CR70","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1161\/01.res.78.2.225","volume":"78","author":"R Sarkar","year":"1996","unstructured":"Sarkar R, Meinberg EG, Stanley JC, Gordon D, Clinton Webb R. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res. 1996;78:225\u201330. https:\/\/doi.org\/10.1161\/01.res.78.2.225.","journal-title":"Circ Res"},{"key":"4012_CR71","doi-asserted-by":"publisher","first-page":"E3095","DOI":"10.1073\/pnas.1500851112","volume":"112","author":"A Micsonai","year":"2015","unstructured":"Micsonai A, Wien F, Kernya L, Lee Y-H, Goto Y, R\u00e9fr\u00e9giers M, et al. Accurate secondary structure prediction and fold recognition for circular dichroism spectroscopy. Proc Natl Acad Sci U S A. 2015;112:E3095-103. https:\/\/doi.org\/10.1073\/pnas.1500851112.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4012_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s40580-025-00518-w","volume":"12","author":"C Lin","year":"2025","unstructured":"Lin C, Hsu F-Y, Shih C-M, Cheng T-M, Wu AT, Cheng C-H, et al. Programmable MRI contrast switching for spatiotemporal mapping of thrombus maturation via enzyme-directed nanoprobe reconfiguration. Nano Convergence. 2025;12:53. https:\/\/doi.org\/10.1186\/s40580-025-00518-w.","journal-title":"Nano Convergence"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-04012-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-04012-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-04012-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T05:15:00Z","timestamp":1768540500000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-025-04012-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4012"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-04012-7","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"22 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted in accordance with the guidelines of the Institutional Animal Care and Use Committee (IACUC) of Taipei Medical University, and were approved under protocol number LAC-2021-0464. Not applicable for studies involving human participants, human data, or human tissues.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable. This manuscript does not contain data from any individual person.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}